Search Results 1761-1770 of 19634 for Hemoglobin

1. A Study to Evaluate a Standard-dose and High- dose Regimen of Encorafenib + Binimetinib in Patients with BRAFV600-mutant Melanoma Brain Metastasis - Mayo Clinic

   Hemoglobin ≥ 9 g/dL with or without transfusions;; Platelets ≥ 100 × 10^9 /L;; AST and ALT ≤ 2.5 × ULN; in patients with liver metastases ≤ 5 × ULN;; Total ...

2. A Study to Evaluate the Effectiveness and Safety of Cobomarsen (MRG-106) vs. Active Comparator in Subjects with Mycosis Fungoides - Mayo Clinic

   Clinically significant anemia (hemoglobin < 8 g/dL), neutropenia (absolute neutrophil count [ANC] < 1000/mm3) or thrombocytopenia (platelets < 50,000/mm^3) at ...

3. A Study to Evaluate TG4050 in Ovarian Carcinoma - Mayo Clinic

   Hemoglobin ≥ 9.0 g/dL;; Neutrophils count ≥ 1.5 x10^9 /L;; Lymphocytes count ≥ 0.9 x10^9 /L;; Platelets count ≥ 100 x10^9 /L;; Total bilirubin ≤ 1.5 x ULN ...

4. Sequential Testosterone and Enzalutamide Prevents Unfavorable Progression - Mayo Clinic

   Hemoglobin ≥ 8 g/dL. At least 4 weeks since prior radiation or chemotherapy. Ability to understand and willingness to sign a written informed consent ...

5. Chemotherapy Combined With Immunotherapy vs Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial - Mayo Clinic

   - Hemoglobin (Hgb) ≥ 8.0 g/dL (obtained within 14 days prior to Step 1 registration) - Total bilirubin ≤ 1.5 x institutional upper limit of normal (ULN) ...

6. A Study of Subcutaneous Daratumumab Versus Active Monitoring in Participants With High-Risk Smoldering Multiple Myeloma - Mayo Clinic

   Anemia, defined as hemoglobin <10 g/dL or >2 g/dL below lower limit of normal or both; transfusion support or concurrent treatment with erythropoietin ...

7. A Study of ABC294640 (Yeliva®) in the Treatment of Patients with Advanced Cholangiocarcinoma - Mayo Clinic

   Hemoglobin ≥ 9 g/dL. Acceptable blood sugar control: Fasting glucose value ≤ 160 mg/dL (NCI-CTCAE Grade 1 baseline). Urinalysis: No clinically significant ...

8. Deucravacitinib (BMS-986165) for Pityriasis Rubra Pilaris - Mayo Clinic

   ALT or AST > 2 x upper limits of normal (ULN); alkaline phosphatase (ALP) ≥ 2 x ULN; total bilirubin ≥ 1.5 x ULN; hemoglobin < 10 g/dL (100.0 g/L); total ...

9. TUESDAY Q & A: Vitamin B-12 deficiency more common with increasing age - Mayo Clinic News Network

   DEAR MAYO CLINIC: I recently read that being deficient in vitamin B-12 is common. Should I take a supplement? I am 78 and in good health.

10. A Study Evaluating the Efficacy and Safety of Obinutuzumab in Participants With Primary Membranous Nephropathy - Mayo Clinic

    Hemoglobin < 9 g/dL;; Platelet count < 75,000/µL;; Positive serum human chorionic gonadotropin measured at screening. Eligibility last updated 12/2/21 ...